An ageing population, rising antimicrobial resistance, and the ongoing threat of infectious and chronic diseases are placing immense pressure on our societies. A shift to a preventative approach is necessary for the efficiency and sustainability of our healthcare systems. Central to this shift is the often-underutilized tool of life-course immunization.
Public Health England is urging students to get MenACWY and MMR vaccines before the start of the new college or university year to ensure they're protected against deadly diseases
New data published by Public Health England (PHE) show that deaths from hepatitis C-related end-stage liver disease have fallen by 11% in 2017 compared to the previous year
The work of Vytenis Andriukaitis, European Commissioner for Health & Food Safety, with responsibility for modernising health policy, building up knowledge and tackling preventable diseases
Professor John Wilding from the University of Liverpool charts priorities for improving patient care in the UK when it comes to the prevalent condition, Type 2 diabetes
Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explains why air matters, for everybody, everywhere (H2)
Helen McShane, Professor of Vaccinology at The Jenner Institute, University of Oxford reveals the current status of tuberculosis vaccine development in the world today.
Boris Šustaršič, President of the European Alliance of Neuromuscular Disorders Associations shares his thoughts on the key issues around muscular dystrophy (MD) in Europe today
Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
Today, The Aplastic Anaemia Trust (AAT) launches their new research strategy, inviting prospective applicants to come forward with proposals for truly translational research into aplastic anaemia (AA), as CEO Grazina Berry reveals
Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease
